Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4454621 | 0.83 | TDP1 (0.39) | — | |
| SCHEMBL17909924 | 0.82 | — | — | |
| SCHEMBL6269143 | 0.78 | CES2 (0.39) | ALDH1A1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL16624283 | 0.73 | MGAM (0.46) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL262554 | 0.73 | LDHA (0.38) | ALDH1A1FFAR3TSHRLMNA | |
| SCHEMBL4454619 | 0.73 | MGAM (0.46) | ALDH1A1TSHR | |
| SCHEMBL3233649 | 0.73 | TSHR (0.32) | ALDH1A1TSHRCA1CA2 | |
| SCHEMBL21294536 | 0.73 | LDHA (0.38) | ALDH1A1FFAR3TSHRLMNA | |
| SCHEMBL16215829 | 0.72 | CES2 (0.52) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL28164796 | 0.72 | HDAC1 (0.39) | HDAC3HDAC1HDAC2HDAC8CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7595414-B2 | complex capable of being used for chemical vapor deposition of thin metal , or metal oxide films | UBE INDUSTRIES, LTD. (JP) | 2009-09-29 | — | — | US | disclosed |
| US-20080254216-A1 | Metal Complex Compound Comprising B-Diketonato Ligand | UBE INDUSTRIES, LTD. (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254216-A1 | Metal Complex Compound Comprising B-Diketonato Ligand | CAD, APOB, DBI | ALDH1A1 3881/4885HDAC3 2495/4885HDAC1 1412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.